AKT1 and skin cancer: Some studies have also shown that lncROR can inhibit P3 activity by activating PI53K/AKT, promoting the proliferation of arsenite-transformed keratinocytes, and providing a new carcinogenic mechanism for arsenite-induced skin cancer [19].